repaglinide glp 1 Glucagon-like peptide-1 (GLP-1) receptor agonists: applications in childhood diabetes and obesity Oral GLP-1 Therapy 2026: Will

Effects of salinity on biochemical components of the mangrove, Aegiceras corniculatum

The failure of adipose tissue to expand adequately plays a central role in the development of insulin resistance and T2D

GLP-1 therapies are reshaping obesity, diabetes, and even cardiovascular care Demand has outpaced global manufacturing capacity A grey market has emerged and regulators are now stepping in to contain it Patients want affordable, available treatment

This multidisciplinary approach is grounded in systems biology and supported by evidence from peer-reviewed research across nutritional sciences, metabolomics, microbiome biology, and pharmacogenomics